![Fluoropyrimidine chemotherapy: recommendations for DPYD genotyping and therapeutic drug monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy | Swiss Medical Weekly Fluoropyrimidine chemotherapy: recommendations for DPYD genotyping and therapeutic drug monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy | Swiss Medical Weekly](https://smw.ch/index.php/smw/article/download/2899/version/2899/4749/14562/2120723273905356048_w20375_f1_conv.jpg)
Fluoropyrimidine chemotherapy: recommendations for DPYD genotyping and therapeutic drug monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy | Swiss Medical Weekly
![Teva Parenteral Medicines Initiates Voluntary Nationwide Recall of Select Lots of Adrucil® (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) Due to Particulate Matter | Business Wire Teva Parenteral Medicines Initiates Voluntary Nationwide Recall of Select Lots of Adrucil® (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) Due to Particulate Matter | Business Wire](https://mms.businesswire.com/media/20150724005534/en/478384/4/Adrucil2.jpg)
Teva Parenteral Medicines Initiates Voluntary Nationwide Recall of Select Lots of Adrucil® (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) Due to Particulate Matter | Business Wire
![Adrucil<br> Antineoplastic Agent Fluorouracil <br>50 mg / mL Intravenous Injection <br>Pharmacy Bulk Vial 50 mL , 5/Case <br> Teva 00703301812 Adrucil<br> Antineoplastic Agent Fluorouracil <br>50 mg / mL Intravenous Injection <br>Pharmacy Bulk Vial 50 mL , 5/Case <br> Teva 00703301812](https://s.turbifycdn.com/aah/yhst-12533177228474/adrucil-antineoplastic-agent-fluorouracil-50-mg-ml-intravenous-injection-pharmacy-bulk-vial-50-ml-5-case-teva-00703301812-40.gif)